Dina George Lansey,Rohan Ramalingam,Otis W Brawley
Dina George Lansey
The United States has seen a 33% decline in age-adjusted cancer mortality since 1991. Despite this achievement, the United States has some of the greatest health disparities of any developed nation. US government policies are increasingly d...
Lori J Pierce
Lori J Pierce
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes: Systematic Review and Meta-analysis [0.03%]
肝转移对患者预后影响的系统评价和meta分析
Jessica J Waninger,Vincent T Ma,Zoey Chopra et al.
Jessica J Waninger et al.
The liver is a common site of metastasis for many primary malignancies, but the quantitative impact on survival is unknown. We performed a systematic review and meta-analysis of 83 studies (604,853 patients) assessing the overall hazard ass...
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma? [0.03%]
分子影像时代放射治疗在肝内胆管癌中扮演着什么角色?
Eugene J Koay,Milind Javle,Madeline Belknap et al.
Eugene J Koay et al.
Intrahepatic cholangiocarcinoma is a rare disease, yet with rising incidence globally. Most patients are not eligible for potentially curative surgical resection, and many patients with unresectable disease die within 12 months of diagnosis...
Ameer L Elaimy,Yue Cao,Theodore S Lawrence
Ameer L Elaimy
Stereotactic body radiation therapy has emerged as a safe and effective treatment modality for properly selected hepatocellular cancer (HCC) patients with normal liver function. However, many HCC patients have reduced baseline liver functio...
Satender Pal Singh,Vinod Arora,Tushar Madke et al.
Satender Pal Singh et al.
Hepatocellular carcinoma (HCC) is one of the leading cancers worldwide. Classically, HCC develops in genetically susceptible individuals who are exposed to risk factors, especially in the presence of liver cirrhosis. Significant temporal an...
Zurabi Lominadze,Mohammed Rifat Shaik,Dabin Choi et al.
Zurabi Lominadze et al.
Hepatocellular carcinoma (HCC) represents a significant global burden, with management complicated by its heterogeneity, varying presentation, and relative resistance to therapy. Recent advances in the understanding of the genetic, molecula...
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma [0.03%]
头颈部鳞状细胞癌适应性放疗中 interim 正电子发射断层扫描成像的实用性分析
Benjamin S Rosen,Neil Vaishampayan,Yue Cao et al.
Benjamin S Rosen et al.
In this article, as part of this special issue on biomarkers of early response, we review the current evidence to support the use of positron emission tomography (PET) imaging during chemoradiation therapy to inform biologically adaptive ra...
Is Apparent Diffusion Coefficient Established as an Imaging Biomarker for Stereotactic Body Radiation Therapy Assessment in Hepatocellular Carcinoma? [0.03%]
扩散张量成像表型预测肝癌立体定向放疗效果及其机制研究
Yue Cao,Kyle C Cuneo,Joseph Evans et al.
Yue Cao et al.
In this article, as part of this special issue on biomarkers of early response, we review currently available reports regarding magnetic resonance imaging apparent diffusion coefficient (ADC) changes in hepatocellular carcinoma (HCC) in res...
Tumor-Derived Exosomes and the Role of Liquid Biopsy in Human Papillomavirus Oropharyngeal Squamous Cell Carcinoma [0.03%]
人乳头瘤病毒型口咽鳞癌的肿瘤源性外泌体和液态活检的作用
Michael M Allevato,Joshua D Smith,Michael J Brenner et al.
Michael M Allevato et al.
The global incidence of human papillomavirus-positive (HPV+) head and neck squamous cell carcinoma (HNSCC) has surged in recent decades, with HPV+ HNSCC accounting for >70% of oropharynx cancers in the United States. Its incidence in men ha...